LOAMS
IART icon

Lombard Odier Asset Management (Switzerland)’s Integra LifeSciences IART Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-70,000
Closed -$3.82M – 375
2017
Q2 		$3.82M Sell
70,000
-110,000
-61% -$5.25M 0.44% 52
2017
Q1 		$7.58M Hold
180,000
– – 0.84% 36
2016
Q4 		$7.72M Buy
180,000
+108,000
+150% +$4.39M 1.95% 16
2016
Q3 		$2.97M Buy
+72,000
New +$3.02M 0.71% 29

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s IART Position: Q3 2017 in Review

Lombard Odier Asset Management (Switzerland) sold out of Integra LifeSciences (IART) in Q3 2017, closing a stake of 70,000 shares — an estimated $3.82M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in IART in Q3 2016 and held it in 4 quarters. The position peaked at $7.72M in Q4 2016. 213 funds tracked by Wall St. Rank hold IART as of Q3 2017.

  • Lombard Odier Asset Management (Switzerland) reported no remaining Integra LifeSciences position as of Q3 2017 after selling out during the quarter.
  • Lombard Odier Asset Management (Switzerland) sold 70,000 Integra LifeSciences shares in Q3 2017, an estimated $3.82M.
  • Lombard Odier Asset Management (Switzerland) first reported a position in Integra LifeSciences in Q3 2016 and held it in 4 quarters.
  • Lombard Odier Asset Management (Switzerland)'s Integra LifeSciences position peaked at $7.72M in Q4 2016.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2017.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q3 2017, filed 14 Nov 2017.